Balancing act: Haemoglobinopathies and malaria

The Lancet Infectious Diseases

Volumn 12, Issue 6, 2012, Pages 427-428

  Williams, Thomas N ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN; HEMOGLOBIN C; HEMOGLOBIN S;

BETA THALASSEMIA; HAPLOTYPE; HEMOGLOBINOPATHY; HUMAN; MALARIA; MALARIA FALCIPARUM; NONHUMAN; NOTE; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 84861342721     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(12)70067-1     Document Type: Letter

References (8)

1. Haldane JBS The rate of mutation of human genes. Hereditas 1949, 35:267-273.
2. Taylor SM, Parobek CM, Fairhurst RM Haemoglobinopathies and the clinical epidemiology of malaria: a systematic review and meta-analysis. Lancet Infect Dis 2012, published online March 23. 10.1016/S1473-3099(12)70055-5.
3. Flint J, Harding RM, Boyce AJ, Clegg JB The population genetics of the haemoglobinopathies. Baillieres Clin Haematol 1998, 11:1-51.
4. Murray CJ, Rosenfeld LC, Lim SS, et al. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431.
5. Williams TN How do hemoglobins S and C result in malaria protection?. J Infect Dis 2011, 204:1651-1653.
6. +-thalassemia and the sickle cell trait. Nat Genet 2005, 37:1253-1257.
7. Penman BS, Pybus OG, Weatherall DJ, Gupta S Epistatic interactions between genetic disorders of hemoglobin can explain why the sickle-cell gene is uncommon in the Mediterranean. Proc Natl Acad Sci USA 2009, 106:21242-21246.
8. Allen SJ, O'Donnell A, Alexander ND, et al. Alpha(+)thalassemia protects children against disease caused by other infections as well as malaria. Proc Natl Acad Sci USA 1997, 94:14736-14741.